Effect of detecting and isolating clostridium difficile carriers at hospital admission on the incidence of C difficile infections A quasi-experimental controlled study

JAMA Internal Medicine

Volumn 176, Issue 6, 2016, Pages 796-804

  Longtin, Yves ^a,b   Paquet Bolduc, Bianka ^c   Gilca, Rodica ^d,e,f   Garenc, Christophe ^d,g   Fortin, Elise ^d   Longtin, Jean ^d,e,f,g   Trottier, Sylvie ^c,e,f,g   Gervais, Philippe ^c,e,f   Roussy, Jean Francois ^c,e,f   Levesque, Simon ^d   Ben David, Debby ^h   Cloutier, Isabelle ^c   Loo, Vivian G ^b,i  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g LAVAL UNIVERSITY   (Canada)

^h SHEBA MEDICAL CENTER   (Israel)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE INFECTION; CONTACT ISOLATION; CONTROLLED STUDY; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; TIME SERIES ANALYSIS; CANADA; CLINICAL TRIAL; CLOSTRIDIUM INFECTIONS; COMPARATIVE STUDY; CROSS INFECTION; DISEASE OUTBREAKS; GENETICS; HETEROZYGOTE; HOSPITAL EMERGENCY SERVICE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; PSEUDOMEMBRANOUS COLITIS; QUEBEC; RECTUM; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UNIVERSITY HOSPITAL;

CANADA; CARRIER STATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; EMERGENCY SERVICE, HOSPITAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; PATIENT ADMISSION; QUEBEC; RECTUM; RETROSPECTIVE STUDIES;

EID: 84973444577     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.0177     Document Type: Article

References (38)

1. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539-1548.
2. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/. Published September 16, 2013. Accessed September 23, 2015.
4. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ. 2004;171(5):466-472.
5. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.
6. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366 (9491):1079-1084.
7. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353 (23):2442-2449.
8. Institut National de Sante Publique du Quebec. Surveillance des diarrhees associees a Clostridium difficile au Quebec: bilan du 5 Decembre 2010 au 31 Mars. http://www.inspq.qc.ca/pdf/publications/1389-SurvCDifficile-5dec2010Au31mars2011.pdf. Published 2011. Accessed September 23, 2015.
9. Dubberke ER, Carling P, Carrico R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(suppl 2):S48-S65.
10. Vonberg RP, Kuijper EJ, Wilcox MH, et al; European C difficile-Infection Control Group; European Centre for Disease Prevention and Control (ECDC). Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008;14(suppl 5):2-20.
11. Lanzas C, Dubberke ER, Lu Z, Reske KA, Grohn YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553-561.
12. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992-998.
13. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336 (8707):97-100.
14. Galdys AL, Curry SR, Harrison LH. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2014;12(8):967-980.
15. Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis. 2008;46(3):447-450.
16. Lanzas C, Dubberke ER. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: A modeling evaluation. Infect Control Hosp Epidemiol. 2014;35(8):1043-1050.
17. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693- 1703.
18. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis. 2007;7(4):282-288.
19. Comite de Surveillance Provinciale des Infections Nosocomiales (SPIN). Diarrhees associees au Clostridium difficile: Resultats de surveillance 2013-2014: Institut National de Sante Publique Quebec. https://www.inspq.qc.ca/infectionsnosocomiales/spin-cd/surveillance-2013-2014. Published 2014. Accessed September 20, 2015.
20. Hubert B, Loo VG, Bourgault AM, et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis. 2007;44(2):238-244.
21. Gilca R, Hubert B, Fortin E, Gaulin C, Dionne M. Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998-2006. Infect Control Hosp Epidemiol. 2010;31 (9):939-947.
22. Institut National de Sante Publique du Quebec. Surveillance des diarrhees associees au Clostridium difficile dans les centres hospitaliers du Quebec: protocole: version 3. https://www.inspq.qc.ca/sites/default/files/documents/infectionsnosocomiales/protocoledacd-v3.pdf. Published February 2013. Accessed August 15, 2015.
23. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol. 2010;31(1):21-27.
24. Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67-73.
25. Belanger SD, Boissinot M, Clairoux N, Picard FJ, Bergeron MG. Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol. 2003;41(2):730-734.
26. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50(2):194-201.
27. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-2239.
28. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309.
29. Helfenstein U. The use of transfer function models, intervention analysis and related time seriesmethods in epidemiology. Int J Epidemiol. 1991;20(3):808-815.
30. Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res. 1996;5(1): 3-22.
31. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. http://www.whocc.no/filearchive/publications/1-2013guidelines.pdf Published 2012. Accessed September 23, 2015.
32. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369 (13):1195-1205.
33. Archbald-Pannone LR, Boone JH, Carman RJ, Lyerly DM, Guerrant RL. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect. 2014;88(4):218-221.
34. World Health Organization. WHO guidelines on hand hygiene in health care. http://apps.who.int/iris/bitstream/10665/44102/1/9789241597906-eng.pdf. Published 2009. Accessed September 23, 2015.
35. Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: A systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381- 390.
36. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M. Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: A time series analysis in Quebec, Canada. Antimicrob Agents Chemother. 2012;56(2):639-646.
37. Bartsch SM, Curry SR, Harrison LH, Lee BY. The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis. 2012;31(11):3163-3171.
38. Kwon JH, Olsen MA, Dubberke ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123-134.